Star Imaging and Path Lab Ratios

Star Imaging and Path Lab Ltd Ratios

The Star Imaging and Path Lab Ltd Ratios page provides a complete fundamental analysis of Star Imaging and Path Lab Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Star Imaging and Path Lab Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Star Imaging and Path Lab Ltd (NSE: , BSE: 544482) is currently trading at ₹50.16, with a market capitalization of ₹873.79M. As a major player in the Health services sector and Medical/Nursing services industry, Star Imaging and Path Lab Ltd remains a key stock for fundamental analysis using Star Imaging and Path Lab Ltd Ratios.

Star Imaging and Path Lab Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Star Imaging and Path Lab Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Star Imaging and Path Lab Ltd Ratios.

Historically, the Star Imaging and Path Lab Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Star Imaging and Path Lab Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Star Imaging and Path Lab Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Star Imaging and Path Lab Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Star Imaging and Path Lab Ltd P/S ratio currently stands at 0, an important part of Star Imaging and Path Lab Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Star Imaging and Path Lab Ltd P/S ratio indicates cautious market sentiment.

Star Imaging and Path Lab Ltd Price to Cash Flow Ratio (P/CF)

The Star Imaging and Path Lab Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Star Imaging and Path Lab Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The declining Star Imaging and Path Lab Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Star Imaging and Path Lab Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Star Imaging and Path Lab Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Star Imaging and Path Lab Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Star Imaging and Path Lab Ltd EV/EBITDA ratio is currently 0, a key metric in Star Imaging and Path Lab Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Star Imaging and Path Lab Ltd EV/EBITDA indicates balanced valuation.

Star Imaging and Path Lab Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Star Imaging and Path Lab Ltd D/E ratio is currently 0.69, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.69
• 2023: 0.98
• 2022: 1.40
• 2021: 1.61

Star Imaging and Path Lab Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Star Imaging and Path Lab Ltd ROE currently stands at 40.57%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 40.57
• 2023: 44.43
• 2022: 3.10
• 2021: 0

Star Imaging and Path Lab Ltd demonstrates strong profitability and efficient capital utilization.

Star Imaging and Path Lab Ltd Ratios Analysis Summary

The Star Imaging and Path Lab Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Star Imaging and Path Lab Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Star Imaging and Path Lab Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.